老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Nurix Therapeutics

22.13
-0.0300-0.14%
盘后：22.190.0621+0.28%18:00 EDT
成交量：468.08万
成交额：1.05亿
市值：22.88亿
市盈率：-6.49
高：23.24
开：22.16
低：21.75
收：22.16
52周最高：28.23
52周最低：9.14
股本：1.03亿
流通股本：7,411.19万
量比：2.46
换手率：6.32%
股息：- -
股息率：- -
每股收益(TTM):-3.4102
每股收益(LYR):-3.0514
净资产收益率：-80.30%
总资产收益率：-40.06%
市净率：5.68
市盈率(LYR):-7.25

数据加载中...

总览公司新闻资讯公告
2021/03/02

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

重要事件披露

8-K - Current report
2021/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/07

重要事件披露

8-K - Current report
2020/10/26

重要事件披露

8-K - Current report
2020/10/14

重要事件披露

8-K - Current report
2020/10/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/14

重要事件披露

8-K - Current report
2020/08/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/07/23

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/21

SEC问询函

CORRESP [Cover] - Correspondence
更多